TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FBLG

FibroBiologics, Inc.

Healthcare · Biotechnology

0.9201$ -1.1% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns FibroBiologics, Inc. (FBLG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.3% of the shares are freely tradable; institutional investors hold 12.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 12.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 12.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 73.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 7Mio.

Largest Shareholders

Institutions

Institutions FBLG
Name Stake (%) Shares Change (%) Date
Fund Evaluation Group, LLC 0.74 51,794 +0.0 06/30/2026
Geode Capital Management, LLC 0.44 30,299 +2.3 06/30/2026
Vanguard Capital Management, LLC 0.40 27,769 -59.0 06/30/2026
Qube Research & Technologies 0.35 24,313 +0.0 06/30/2026
BlackRock Inc 0.26 18,238 -26.0 06/30/2026
Barclays PLC 0.10 7,243 +0.0 06/30/2026
Vanguard Fiduciary Trust Co 0.09 6,380 +0.0 06/30/2026
Tower Research Capital LLC 0.07 4,728 +927.8 06/30/2026

Funds

Funds FBLG
Name Stake (%) Shares Change (%) Date
T. Rowe Price M-A Glb Inc I USD 4.02 280,000 +0.0 08/31/2026
Fidelity Extended Market Index 0.35 24,249 -0.5 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings FBLG
Person Role Shares Value As of Type
Khoja Hamid Chief Scientific Officer 301,571 277,475 $ Sep 15, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 15, 2026 Khoja Hamid Chief Scientific Officer Other 298,508 1.68 500,001

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?